<scp>TACE</scp> versus <scp>TARE</scp> for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis-Reference-Cited by-同舟云学术

TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis

Published:2022-08-09 Issue:3 Volume:12 Page:2590-2599
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Brown Andrew M.¹,Kassab Ihab¹,Massani Marco²,Townsend Whitney¹,Singal Amit G.³^ORCID,Soydal Cigdem⁴,Moreno‐Luna Laura⁵,Roberts Lewis R.⁵,Chen Vincent L.¹,Parikh Neehar D.¹^ORCID

Affiliation:

1. Division of Gastroenterology and University of Michigan Ann Arbor Michigan USA

2. Ospedale Regionale Treviso Treviso Italy

3. Division of Digestive and Liver Diseases University of Texas Southwestern Dallas Texas USA

4. Department of Nuclear Medicine Ankara University Medical School Ankara Turkey

5. Division of Gastroenterology and Hepatology Mayo Clinic Rochester Minnesota USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5125

Reference41 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis

3. Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient Analysis

4. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

5. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation and Management of Unresectable Hepatocellular Carcinoma: Multidisciplinary Indian Consensus Statements from a Delphi Panel;South Asian Journal of Cancer;2024-07-22

2. Comparison of Transarterial Chemoembolization vs Radioembolization for Large Unresectable Hepatocellular Carcinoma (>8cm): A Propensity Score Matching Analysis.;2024-07-18

3. Examining the Efficacy and Safety of Combined Locoregional Therapy and Immunotherapy in Treating Hepatocellular Carcinoma;Biomedicines;2024-06-27

4. The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes;Cancers;2024-06-24

5. Prognostic Value of Liver Biomarkers in Hepatocellular Carcinoma Patients Undergoing Yttrium 90 Transarterial Radioembolization (TARE): A Retrospective Pilot Study;Cureus;2024-06-07